550,000 doses of the two-shot Chinese Sinopharm vaccine arrived in Hungary on Tuesday, making it the first EU country to receive the Chinese vaccine.
Vaccinations with the jab, however, can only start after the National Public Health Centre gives its final blessing, after the authorities have issued a conditional marketing authorisation last month. Hungary has purchased a total of 5 million doses, enough for 2.5 million people.
This makes the Chinese jab the fifth product to enter use in Hungary, after Western-produced vaccines and Russian Sputnik V, with which vaccinations began last week.
Earlier this week, EU sources told EURACTIV.com that member states can approve vaccines not authorised yet by EMA, but “with their own responsibility” when it comes to the safety of these vaccines.
(Vlagyiszlav Makszimov | EURACTIV.com with Telex)